L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.322 GBX -0.72% Market Closed
Market Cap: 134.1m GBX
Have any thoughts about
Life Science REIT PLC?
Write Note
LABS
/
Income Statement
/
Revenue

Life Science REIT PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Life Science REIT PLC
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
L
Life Science REIT PLC
LSE:LABS
Revenue
£19.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Primary Health Properties PLC
LSE:PHP
Revenue
£177.8m
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
13%
Assura PLC
LSE:AGR
Revenue
£157.8m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Target Healthcare REIT PLC
LSE:THRL
Revenue
£67.8m
CAGR 3-Years
12%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Impact Healthcare REIT PLC
LSE:IHR
Revenue
£54.2m
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
N/A
No Stocks Found

Life Science REIT PLC
Glance View

Market Cap
134.1m GBX
Industry
Real Estate

Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.

LABS Intrinsic Value
56.874 GBX
Undervaluation 33%
Intrinsic Value
Price
L
What is Intrinsic Value?

See Also

What is Life Science REIT PLC's Revenue?
Revenue
19.9m GBP

Based on the financial report for Dec 31, 2023, Life Science REIT PLC's Revenue amounts to 19.9m GBP.

What is Life Science REIT PLC's Revenue growth rate?
Revenue CAGR 1Y
27%

Over the last year, the Revenue growth was 27%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.